Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025 GlobeNewswire December 03, 2025 Fort Lauderdale, FL, Dec. 03, 2025 (GLOBE NEWSWIRE) — Drugs Made In America Acquisition II Corp. (the “Company“), a special purpose acquisition company formed as a Cayman Islands exempted company, […]